Frank Ahmann

Frank Ahmann is a senior executive with extensive experience in the biotech and medical device industries, currently serving as the Chief Business Officer at TriFlo Cardiovascular Inc.12 With a career spanning 30 years, Ahmann has established himself as a prominent figure in the field.

Professional Background

Ahmann's professional journey includes several notable positions:

• Chief Business Officer at TriFlo Cardiovascular Inc., where he contributes his wealth of experience to the company's strategic direction.2
• Previously served as President and CEO of LoneStar Heart, Inc., focusing on cardiac-related technologies.5
• Held the position of President and COO at Lonestar Heart Inc., demonstrating his leadership capabilities in executive roles.6

Expertise and Achievements

Frank Ahmann has demonstrated a strong track record in:

• Successfully developing and commercializing medical technologies.2
• Contributing to advancements in cardiovascular treatments, particularly in areas such as tricuspid valve regurgitation.34
• Cardiac tissue engineering, with a specific interest in treatments for advanced heart failure.5

Education

Ahmann's educational background includes:

• A degree from Columbia University, which has likely contributed to his success in the biomedical field.1

Recent Activities

In his role at TriFlo Cardiovascular, Ahmann has been involved in:

• Presenting clinical outcomes of tricuspid valve regurgitation patients treated with the company's Tricuspid Flow Optimizer in Italy.3
• Addressing technological gaps in treating a broader population of tricuspid regurgitation patients.4

Frank Ahmann's LinkedIn profile (username: frank-ahmann-557bb97) serves as a professional platform where he shares updates and insights related to his work in the cardiovascular medical device industry.13